Rajan KB, Weuve J, Barnes LL, McAninch EA, Wilson RS, Evans DA. Population estimate of people with clinical Alzheimer’s disease and mild cognitive impairment in the United States (2020–2060). Alzheimers Dement. 2021;17:2020–60.
Article
Google Scholar
Hurd MD, Martorell P, Delavande A, Mullen KJ, Langa KM. Monetary costs of dementia in the United States. N Engl J Med. 2013;368:1326–34.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ferreira D, Wahlund LO, Westman E. The heterogeneity within Alzheimer’s disease. Aging (Albany NY). 2018;10:3058–60.
Article
Google Scholar
Ferretti MT, Iulita MF, Cavedo E, Chiesa PA, Schumacher Dimech A, Santuccione Chadha A, et al. Sex differences in Alzheimer disease - the gateway to precision medicine. Nat Rev Neurol. 2018;14:457–69.
Article
PubMed
Google Scholar
Mazure CM, Swendsen J. Sex differences in Alzheimer’s disease and other dementias. Lancet Neurol. 2016;15:451–2.
Article
PubMed
PubMed Central
Google Scholar
Nebel RA, Aggarwal NT, Barnes LL, Gallagher A, Goldstein JM, Kantarci K, et al. Understanding the impact of sex and gender in Alzheimer’s disease: A call to action. Alzheimers Dement. 2018;14:1171–83.
Article
PubMed
PubMed Central
Google Scholar
Hampel H, Vergallo A, Giorgi FS, Kim SH, Depypere H, Graziani M, et al. Alzheimer Precision Medicine I: Precision medicine and drug development in Alzheimer’s disease: the importance of sexual dimorphism and patient stratification. Front Neuroendocrinol. 2018;50:31–51.
Article
PubMed
Google Scholar
Lin KA, Doraiswamy PM. When Mars versus Venus is not a cliche: gender differences in the neurobiology of Alzheimer’s disease. Front Neurol. 2014;5:288.
PubMed
Google Scholar
Hebert LE, Weuve J, Scherr PA, Evans DA. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology. 2013;80:1778–83.
Article
PubMed
PubMed Central
Google Scholar
Koran MEI, Wagener M, Hohman TJ. Alzheimer’s Neuroimaging I: Sex differences in the association between AD biomarkers and cognitive decline. Brain Imaging Behav. 2017;11:205–13.
Article
PubMed
PubMed Central
Google Scholar
Tschanz JT, Corcoran CD, Schwartz S, Treiber K, Green RC, Norton MC, et al. Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study. Am J Geriatr Psychiatry. 2011;19:532–42.
Article
PubMed
PubMed Central
Google Scholar
Davis EJ, et al. A second X chromosome contributes to resilience in a mouse model of Alzheimer’s disease. Sci Transl Med. 2020;12:eaaz5677.
Lapane KL, Gambassi G, Landi F, Sgadari A, Mor V, Bernabei R. Gender differences in predictors of mortality in nursing home residents with AD. Neurology. 2001;56:650–4.
Article
CAS
PubMed
Google Scholar
Stern Y, Tang MX, Albert MS, Brandt J, Jacobs DM, Bell K, et al. Predicting time to nursing home care and death in individuals with Alzheimer disease. JAMA. 1997;277:806–12.
Article
CAS
PubMed
Google Scholar
Durazzo TC, Mattsson N, Weiner MW. Alzheimer’s Disease Neuroimaging I: Smoking and increased Alzheimer’s disease risk: a review of potential mechanisms. Alzheimers Dement. 2014;10:S122–45.
Article
PubMed
PubMed Central
Google Scholar
Morris MC, Tangney CC, Wang Y, Sacks FM, Bennett DA, Aggarwal NT. MIND diet associated with reduced incidence of Alzheimer’s disease. Alzheimers Dement. 2015;11:1007–14.
Article
PubMed
PubMed Central
Google Scholar
Islam MR, Valaris S, Young MF, Haley EB, Luo R, Bond SF, et al. Exercise hormone irisin is a critical regulator of cognitive function. Nat Metab. 2021;3:1058–70.
Article
CAS
PubMed
Google Scholar
Kubota T, Miyake K, Hirasawa T. Epigenetic understanding of gene-environment interactions in psychiatric disorders: a new concept of clinical genetics. Clin Epigenetics. 2012;4:1.
Article
CAS
PubMed
PubMed Central
Google Scholar
De Jager PL, Srivastava G, Lunnon K, Burgess J, Schalkwyk LC, Yu L, et al. Alzheimer’s disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci. 2014;17:1156–63.
Article
PubMed
PubMed Central
CAS
Google Scholar
Lunnon K, Smith R, Hannon E, De Jager PL, Srivastava G, Volta M, et al. Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer’s disease. Nat Neurosci. 2014;17:1164–70.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang L, Silva TC, Young JI, Gomez L, Schmidt MA, Hamilton-Nelson KL, et al. Epigenome-wide meta-analysis of DNA methylation differences in prefrontal cortex implicates the immune processes in Alzheimer’s disease. Nat Commun. 2020;11:6114.
Article
CAS
PubMed
PubMed Central
Google Scholar
Silva TC, Young JI, Zhang L, Gomez L, Schmidt MA, Varma A, et al. Cross-tissue meta-analysis of blood and brain epigenome-wide association studies in Alzheimer’s disease. Nat Commun. 2022; In Press.
Smith RG, Hannon E, De Jager PL, Chibnik L, Lott SJ, Condliffe D, et al. Elevated DNA methylation across a 48-kb region spanning the HOXA gene cluster is associated with Alzheimer’s disease neuropathology. Alzheimers Dement. 2018;14:1580–8.
Article
PubMed
PubMed Central
Google Scholar
Nabais MF, Laws SM, Lin T, Vallerga CL, Armstrong NJ, Blair IP, et al. Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders. Genome Biol. 2021;22:90.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fransquet PD, Lacaze P, Saffery R, McNeil J, Woods R, Ryan J. Blood DNA methylation as a potential biomarker of dementia: a systematic review. Alzheimers Dement. 2018;14:81–103.
Article
PubMed
Google Scholar
Fransquet PD, Lacaze P, Saffery R, Phung J, Parker E, Shah R, et al. Blood DNA methylation signatures to detect dementia prior to overt clinical symptoms. Alzheimers Dement (Amst). 2020;12:e12056.
Google Scholar
Kobayashi N, Shinagawa S, Niimura H, Kida H, Nagata T, Tagai K, et al. Increased blood COASY DNA methylation levels a potential biomarker for early pathology of Alzheimer’s disease. Sci Rep. 2020;10:12217.
Article
CAS
PubMed
PubMed Central
Google Scholar
Roubroeks JAY, Smith AR, Smith RG, Pishva E, Ibrahim Z, Sattlecker M, et al. An epigenome-wide association study of Alzheimer’s disease blood highlights robust DNA hypermethylation in the HOXB6 gene. Neurobiol Aging. 2020;95:26–45.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fransquet PD, Lacaze P, Saffery R, Phung J, Parker E, Shah RC, et al. DNA methylation analysis of candidate genes associated with dementia in peripheral blood. Epigenomics. 2020;12:2109–23.
Article
CAS
PubMed
PubMed Central
Google Scholar
Madrid A, Hogan KJ, Papale LA, Clark LR, Asthana S, Johnson SC, et al. DNA hypomethylation in blood links B3GALT4 and ZADH2 to Alzheimer’s disease. J Alzheimers Dis. 2018;66:927–34.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mitsumori R, Sakaguchi K, Shigemizu D, Mori T, Akiyama S, Ozaki K, et al. Lower DNA methylation levels in CpG island shores of CR1, CLU, and PICALM in the blood of Japanese Alzheimer’s disease patients. PLoS One. 2020;15:e0239196.
Article
CAS
PubMed
PubMed Central
Google Scholar
McCarthy NS, Melton PE, Cadby G, Yazar S, Franchina M, Moses EK, et al. Meta-analysis of human methylation data for evidence of sex-specific autosomal patterns. BMC Genomics. 2014;15:981.
Article
PubMed
PubMed Central
CAS
Google Scholar
Xu H, Wang F, Liu Y, Yu Y, Gelernter J, Zhang H. Sex-biased methylome and transcriptome in human prefrontal cortex. Hum Mol Genet. 2014;23:1260–70.
Article
CAS
PubMed
Google Scholar
Xia Y, Dai R, Wang K, Jiao C, Zhang C, Xu Y, et al. Sex-differential DNA methylation and associated regulation networks in human brain implicated in the sex-biased risks of psychiatric disorders. Mol Psychiatry. 2021;26:835–48.
Article
CAS
PubMed
Google Scholar
McCartney DL, Zhang F, Hillary RF, Zhang Q, Stevenson AJ, Walker RM, et al. An epigenome-wide association study of sex-specific chronological ageing. Genome Med. 2019;12:1.
Article
PubMed
PubMed Central
CAS
Google Scholar
Zhang L, Young JI, Gomez L, Silva TC, Schmidt MA, Cai J, et al. Sex-specific DNA methylation differences in Alzheimer’s disease pathology. Acta Neuropathol Commun. 2021;9:77.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hamaker EL, Mulder JD. van IMH: Description, prediction and causation: methodological challenges of studying child and adolescent development. Dev Cogn Neurosci. 2020;46:100867.
Article
PubMed
PubMed Central
Google Scholar
Vasanthakumar A, Davis JW, Idler K, Waring JF, Asque E, Riley-Gillis B, et al. Harnessing peripheral DNA methylation differences in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease. Clin Epigenetics. 2020;12:84.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen YA, Lemire M, Choufani S, Butcher DT, Grafodatskaya D, Zanke BW, et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics. 2013;8:203–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang T, Guan W, Lin J, Boutaoui N, Canino G, Luo J, et al. A systematic study of normalization methods for Infinium 450K methylation data using whole-genome bisulfite sequencing data. Epigenetics. 2015;10:662–9.
Article
PubMed
PubMed Central
Google Scholar
Zheng SC, Breeze CE, Beck S, Teschendorff AE. Identification of differentially methylated cell types in epigenome-wide association studies. Nat Methods. 2018;15:1059–66.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang Q, Vallerga CL, Walker RM, Lin T, Henders AK, Montgomery GW, et al. Improved precision of epigenetic clock estimates across tissues and its implication for biological ageing. Genome Med. 2019;11:54.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bollepalli S, Korhonen T, Kaprio J, Anders S, Ollikainen M. EpiSmokEr: a robust classifier to determine smoking status from DNA methylation data. Epigenomics. 2019;11:1469–86.
Article
CAS
PubMed
Google Scholar
Delvin B, Roeder K. Genomic control for association studies. Biometrics. 1999;55:997–1004.
Article
Google Scholar
van Iterson M, van Zwet EW, Consortium B, Heijmans BT. Controlling bias and inflation in epigenome- and transcriptome-wide association studies using the empirical null distribution. Genome Biol. 2017;18:19.
Article
PubMed
PubMed Central
Google Scholar
Efron B. Correlated z-values and the accuracy of large-scale statistical estimates. J Am Stat Assoc. 2010;105:1042–55.
Article
CAS
PubMed
PubMed Central
Google Scholar
Starnawska A, Tan Q, McGue M, Mors O, Borglum AD, Christensen K, et al. Epigenome-wide association study of cognitive functioning in middle-aged monozygotic twins. Front Aging Neurosci. 2017;9:413.
Article
PubMed
PubMed Central
CAS
Google Scholar
Pedersen BS, Schwartz DA, Yang IV, Kechris KJ. Comb-p: software for combining, analyzing, grouping and correcting spatially correlated P-values. Bioinformatics. 2012;28:2986–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mallik S, Odom GJ, Gao Z, Gomez L, Chen X, Wang L. An evaluation of supervised methods for identifying differentially methylated regions in Illumina methylation arrays. Brief Bioinform. 2019;20:2224–35.
Article
CAS
PubMed
Google Scholar
Whitlock MC. Combining probability from independent tests: the weighted Z-method is superior to Fisher’s approach. J Evol Biol. 2005;18:1368–73.
Article
CAS
PubMed
Google Scholar
Zaykin DV. Optimally weighted Z-test is a powerful method for combining probabilities in meta-analysis. J Evol Biol. 2011;24:1836–41.
Article
CAS
PubMed
PubMed Central
Google Scholar
McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, Lowe CB, et al. GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol. 2010;28:495–501.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nasser J, Bergman DT, Fulco CP, Guckelberger P, Doughty BR, Patwardhan TA, et al. Genome-wide enhancer maps link risk variants to disease genes. Nature. 2021;593:238–43.
Article
CAS
PubMed
PubMed Central
Google Scholar
Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18:220.
Article
PubMed
PubMed Central
CAS
Google Scholar
Narayanan M, Huynh JL, Wang K, Yang X, Yoo S, McElwee J, et al. Common dysregulation network in the human prefrontal cortex underlies two neurodegenerative diseases. Mol Syst Biol. 2014;10:743.
Article
PubMed
PubMed Central
CAS
Google Scholar
Zhang B, Gaiteri C, Bodea LG, Wang Z, McElwee J, Podtelezhnikov AA, et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer’s disease. Cell. 2013;153:707–20.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.
Article
PubMed
PubMed Central
CAS
Google Scholar
Min JL, Hemani G, Hannon E, Dekkers KF, Castillo-Fernandez J, Luijk R, et al. Genomic and phenotypic insights from an atlas of genetic effects on DNA methylation. Nat Genet. 2021;53:1311–21.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ng B, White CC, Klein HU, Sieberts SK, McCabe C, Patrick E, et al. An xQTL map integrates the genetic architecture of the human brain’s transcriptome and epigenome. Nat Neurosci. 2017;20:1418–26.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, et al. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat Genet. 2019;51:414–30.
Article
CAS
PubMed
PubMed Central
Google Scholar
Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.
Article
PubMed
PubMed Central
Google Scholar
Mason SJ, Graham NE. Areas beneath the relative operating characteristics (ROC) and relative operating levels (ROL) curves: statistical significance and interpretation. Q J Roy Meteorol Soc. 2002;128:2145–66.
Article
Google Scholar
Mukherjee S, Erickson H, Bastia D. Enhancer-origin interaction in plasmid R6K involves a DNA loop mediated by initiator protein. Cell. 1988;52:375–83.
Article
CAS
PubMed
Google Scholar
Gasparoni G, Bultmann S, Lutsik P, Kraus TFJ, Sordon S, Vlcek J, et al. DNA methylation analysis on purified neurons and glia dissects age and Alzheimer’s disease-specific changes in the human cortex. Epigenetics Chromatin. 2018;11:41.
Article
PubMed
PubMed Central
CAS
Google Scholar
Klein HU, Bennett DA, De Jager PL. The epigenome in Alzheimer’s disease: current state and approaches for a new path to gene discovery and understanding disease mechanism. Acta Neuropathol. 2016;132:503–14.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chibnik LB, Yu L, Eaton ML, Srivastava G, Schneider JA, Kellis M, et al. Alzheimer’s loci: epigenetic associations and interaction with genetic factors. Ann Clin Transl Neurol. 2015;2:636–47.
Article
CAS
PubMed
PubMed Central
Google Scholar
Huls A, Czamara D. Methodological challenges in constructing DNA methylation risk scores. Epigenetics. 2020;15:1–11.
Article
PubMed
Google Scholar
Busse M, Michler E, von Hoff F, Dobrowolny H, Hartig R, Frodl T, et al. Alterations in the peripheral immune system in dementia. J Alzheimers Dis. 2017;58:1303–13.
Article
CAS
PubMed
Google Scholar
Xiong LL, Xue LL, Du RL, Niu RZ, Chen L, Chen J, et al. Single-cell RNA sequencing reveals B cell-related molecular biomarkers for Alzheimer’s disease. Exp Mol Med. 2021;53:1888–901.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pellicano M, Bulati M, Buffa S, Barbagallo M, Di Prima A, Misiano G, et al. Systemic immune responses in Alzheimer’s disease: in vitro mononuclear cell activation and cytokine production. J Alzheimers Dis. 2010;21:181–92.
Article
CAS
PubMed
Google Scholar
Paranjpe MD, Belonwu S, Wang JK, Oskotsky T, Gupta A, Taubes A, et al. Sex-Specific cross tissue meta-analysis identifies immune dysregulation in women with Alzheimer’s disease. Front Aging Neurosci. 2021;13:735611.
Article
CAS
PubMed
PubMed Central
Google Scholar
Choi D, Choi S, Park SM. Effect of smoking cessation on the risk of dementia: a longitudinal study. Ann Clin Transl Neurol. 2018;5:1192–9.
Article
PubMed
PubMed Central
Google Scholar
Matyas N, Keser Aschenberger F, Wagner G, Teufer B, Auer S, Gisinger C, et al. Continuing education for the prevention of mild cognitive impairment and Alzheimer’s-type dementia: a systematic review and overview of systematic reviews. BMJ Open. 2019;9:e027719.
Article
PubMed
PubMed Central
Google Scholar
Wu R, Li A, Sun B, Sun JG, Zhang J, Zhang T, et al. A novel m(6)A reader Prrc2a controls oligodendroglial specification and myelination. Cell Res. 2019;29:23–41.
Article
CAS
PubMed
Google Scholar
Chen X, Wang F, Gan J, Zhang Z, Liang X, Li T, et al. Myelin deficits caused by Olig2 deficiency lead to cognitive dysfunction and increase vulnerability to social withdrawal in adult mice. Neurosci Bull. 2020;36:419–26.
Article
CAS
PubMed
Google Scholar
Sehmbi M, Rowley CD, Minuzzi L, Kapczinski F, Steiner M, Sassi RB, et al. Association of intracortical myelin and cognitive function in bipolar I disorder. Acta Psychiatr Scand. 2018;138:62–72.
Article
CAS
PubMed
Google Scholar
Shigemizu D, Mori T, Akiyama S, Higaki S, Watanabe H, Sakurai T, et al. Identification of potential blood biomarkers for early diagnosis of Alzheimer’s disease through RNA sequencing analysis. Alzheimers Res Ther. 2020;12:87.
Article
CAS
PubMed
PubMed Central
Google Scholar
Quintero OA, DiVito MM, Adikes RC, Kortan MB, Case LB, Lier AJ, et al. Human Myo19 is a novel myosin that associates with mitochondria. Curr Biol. 2009;19:2008–13.
Article
CAS
PubMed
PubMed Central
Google Scholar
Blagov AV, Grechko AV, Nikiforov NG, Borisov EE, Sadykhov NK, Orekhov AN. Role of impaired mitochondrial dynamics processes in the pathogenesis of Alzheimer’s disease. Int J Mol Sci. 2022;23(13):6954.
Article
CAS
PubMed
PubMed Central
Google Scholar
Flannery PJ, Trushina E. Mitochondrial dynamics and transport in Alzheimer’s disease. Mol Cell Neurosci. 2019;98:109–20.
Article
CAS
PubMed
PubMed Central
Google Scholar
Festuccia N, Owens N, Navarro P. Esrrb, an estrogen-related receptor involved in early development, pluripotency, and reprogramming. FEBS Lett. 2018;592:852–77.
Article
CAS
PubMed
Google Scholar
Eum S, Hill SK, Alliey-Rodriguez N, Stevenson JM, Rubin LH, Lee AM, et al. Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders. Neuropsychopharmacology. 2021;46:1802–10.
Article
CAS
PubMed
PubMed Central
Google Scholar
Thathiah A, De Strooper B. The role of G protein-coupled receptors in the pathology of Alzheimer’s disease. Nat Rev Neurosci. 2011;12:73–87.
Article
CAS
PubMed
Google Scholar
Zhao J, Deng Y, Jiang Z, Qing H. G protein-coupled receptors (GPCRs) in Alzheimer’s disease: a focus on BACE1 related GPCRs. Front Aging Neurosci. 2016;8:58.
Article
PubMed
PubMed Central
Google Scholar
Sell GL, Schaffer TB, Margolis SS. Reducing expression of synapse-restricting protein Ephexin5 ameliorates Alzheimer’s-like impairment in mice. J Clin Invest. 2017;127:1646–50.
Article
PubMed
PubMed Central
Google Scholar
Galatro TF, Holtman IR, Lerario AM, Vainchtein ID, Brouwer N, Sola PR, et al. Transcriptomic analysis of purified human cortical microglia reveals age-associated changes. Nat Neurosci. 2017;20:1162–71.
Article
CAS
PubMed
Google Scholar
Redensek S, Trost M, Dolzan V. Genetic determinants of Parkinson’s disease: can they help to stratify the patients based on the underlying molecular defect? Front Aging Neurosci. 2017;9:20.
Article
PubMed
PubMed Central
CAS
Google Scholar
Do CB, Tung JY, Dorfman E, Kiefer AK, Drabant EM, Francke U, et al. Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson’s disease. PLoS Genet. 2011;7:e1002141.
Article
CAS
PubMed
PubMed Central
Google Scholar
International Parkinson Disease Genomics C, Nalls MA, Plagnol V, Hernandez DG, Sharma M, Sheerin UM, et al. Imputation of sequence variants for identification of genetic risks for Parkinson’s disease: a meta-analysis of genome-wide association studies. Lancet. 2011;377:641–9.
Article
CAS
Google Scholar
Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease. Nat Genet. 2014;46:989–93.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sanchez-Mut JV, Glauser L, Monk D, Graff J. Comprehensive analysis of PM20D1 QTL in Alzheimer’s disease. Clin Epigenetics. 2020;12:20.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sanchez-Mut JV, Heyn H, Silva BA, Dixsaut L, Garcia-Esparcia P, Vidal E, et al. PM20D1 is a quantitative trait locus associated with Alzheimer’s disease. Nat Med. 2018;24:598–603.
Article
CAS
PubMed
Google Scholar
Hannon E, Lunnon K, Schalkwyk L, Mill J. Interindividual methylomic variation across blood, cortex, and cerebellum: implications for epigenetic studies of neurological and neuropsychiatric phenotypes. Epigenetics. 2015;10:1024–32.
Article
PubMed
PubMed Central
Google Scholar
Yusipov I, Bacalini MG, Kalyakulina A, Krivonosov M, Pirazzini C, Gensous N, et al. Age-related DNA methylation changes are sex-specific: a comprehensive assessment. Aging (Albany NY). 2020;12:24057–80.
Article
CAS
Google Scholar
Suderman M, Staley JR, French R, Arathimos R, Simpkin A, Tilling K. dmrff: identifying differentially methylated regions efficiently with power and control. bioRxiv. 2018. https://doi.org/10.1101/508556.
Westman E, Simmons A, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, et al. AddNeuroMed and ADNI: similar patterns of Alzheimer’s atrophy and automated MRI classification accuracy in Europe and North America. Neuroimage. 2011;58:818–28.
Article
PubMed
Google Scholar